Dow Up0.15% Nasdaq Up0.21%

Coronado Biosciences, Inc. (CNDO)

1.85 Up 0.10(5.71%) 4:00PM EDT
ProfileGet Profile for:
Coronado Biosciences, Inc.
24 New England Executive Park
Suite 105
Burlington, MA 01803
United States - Map
Phone: 781-652-4500
Fax: 781-652-4545

Index Membership:N/A
Full Time Employees:14

Business Summary 

Coronado Biosciences, Inc., a development stage biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company's principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201, a biologic comprising the microscopic eggs of the porcine whipworm for the treatment of autoimmune diseases, such as Crohn’s disease, ulcerative colitis, multiple sclerosis, autism, psoriasis, and type 1 diabetes; and CNDO-109, a biologic that activates the immune system’s natural killer cells to seek and destroy cancer cells for the treatment of acute myeloid leukemia. Coronado Biosciences, Inc. has strategic alliances and commercial agreements with Ovamed GmbH, Dr. Falk Pharma GmbH, Freie Universität Berlin, UCL Business PCL, and Progenitor Cell Therapy. The company was founded in 2006 and is based in Burlington, Massachusetts.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Coronado Biosciences, Inc.

Corporate Governance 
Coronado Biosciences, Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 3; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Dr. Lindsay Allan Rosenwald M.D., 59
Chairman, Chief Exec. Officer and Pres
Dr. Eric K. Rowinsky M.D., 57
Vice Chairman, Consultant and Member of Strategic Transaction Committee
Dr. Lucy Lu M.D., 39
Chief Financial Officer and Exec. VP
Dr. George Avgerinos Ph.D., 61
Sr. VP of Biologics Operations
Mr. Michael S. Weiss Esq., 48
Exec. Vice Chairman of Strategic Devel. and Director
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders